| DB ID | MyCo_1793 |
| Title | Circulating galectin-3 in infections and non-infectious inflammatory diseases |
| Year | 2013 |
| PMID | 23828453 |
| Fungal Diseases involved | Candidemia |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | spp. |
| Organism | Candida spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Galectin-3 |
| Biomarker Full Name | Galectin-3 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Netherlands |
| Cohort | To assess the capacity of galectin-3 to serve as a biomarker discriminating between different inflammatory states, the plasma concentrations of galectin-3 were measured in 127 patients with either an infection or non-infectious inflamma-tion. |
| Cohort No. | 127 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit (ELISAs; IBL International GmbH, Hamburg, Germany, and R&D Systems, Minneapolis, MN, USA, respectively) |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
